文献速递结核与非结核分枝杆菌艾滋病与性传播感染

结核、HIV与南非半城市地区一过性高血糖的关联

Tuberculosis, Human Immunodeficiency Virus, and the Association With Transient Hyperglycemia in Periurban South Africa.
PubMed 文献 · Clin Infect Dis · 2020-01-01

研究纳入南非开普敦结核门诊成人,以糖化血红蛋白和空腹血糖筛查糖尿病(DM)及糖调节受损(IGR),评估其与结核及HIV感染的关联。入组时DM患病率11.9%、IGR患病率46.9%;结核与DM关联在入组时(OR 2.41)和随访时(OR 3.3)均显著,结核与IGR关联仅在入组时显著(OR 2.3)。HIV-1感染且既往DM者随访时高血糖及结核/DM关联持续存在。

要点

  • 结核门诊成人入组时DM患病率11.9%,IGR患病率46.9%。
  • 结核与DM关联在入组时和3个月随访时均显著。
  • HIV-1感染合并既往DM者随访时高血糖持续。

核心结论

  • 研究显示结核患者入组时一过性高血糖患病率高,新诊断DM者结核与DM/IGR关联显著。
  • HIV-1感染且既往DM者尽管接受结核治疗,随访时高血糖及结核/DM关联持续存在。

研究设计与样本

  • 研究在南非开普敦一家结核门诊纳入成人,结核病例按南非指南定义,非结核者为有呼吸道症状但结核检测阴性且3个月后未抗结核治疗症状缓解者。
  • 通过病历或HIV检测确定HIV状态,所有参与者入组时及3个月后以糖化血红蛋白和空腹血糖筛查DM。
  • 分析结核与DM的关联。

主要发现

  • 入组时DM总体患病率11.9%(95%CI 9.1%-15.4%),随访时9.3%(95%CI 6.4%-13%)。
  • 入组时IGR患病率46.9%(95%CI 42.2%-51.8%),随访时21.5%(95%CI 16.9%-26.3%)。
  • 结核/DM关联在入组时显著(OR 2.41,95%CI 1.3-4.3),随访时亦显著(OR 3.3,95%CI 1.5-7.3)。
  • 结核/IGR关联仅在入组时显著(OR 2.3,95%CI 1.6-3.3)。
  • 结核/DM关联在入组时新诊断和既往DM中均显著,但随访时仅在HIV-1感染且既往DM者中持续存在。

临床怎么用

  • 对结核门诊成人应筛查高血糖,包括糖化血红蛋白和空腹血糖。
  • 对HIV-1感染合并既往DM的结核患者,即使抗结核治疗,仍需随访监测高血糖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes mellitus (DM) increases tuberculosis (TB) risk. We assessed the prevalence of hyperglycemia (DM and impaired glucose regulation [IGR]) in persons with TB and the association between hyperglycemia and TB at enrollment and 3 months after TB treatment in the context of human immunodeficiency virus (HIV) infection. METHODS: Adults presenting at a Cape Town TB clinic were enrolled. TB cases were defined by South African guidelines, while non-TB participants were those who presented with respiratory symptoms, negative TB tests, and resolution of symptoms 3 months later without TB treatment. HIV status was ascertained through medical records or HIV testing. All participants were screened for DM using glycated hemoglobin and fasting plasma glucose at TB treatment and after 3 months. The association between TB and DM was assessed. RESULTS: Overall DM prevalence was 11.9% (95% confidence interval [CI], 9.1%-15.4%) at enrollment and 9.3% (95% CI, 6.4%-13%) at follow-up; IGR prevalence was 46.9% (95% CI, 42.2%-51.8%) and 21.5% (95% CI, 16.9%-26.3%) at enrollment and follow-up. TB/DM association was significant at enrollment (odds ratio [OR], 2.41 [95% CI, 1.3-4.3]) and follow-up (OR, 3.3 [95% CI, 1.5-7.3]), whereas TB/IGR association was only positive at enrollment (OR, 2.3 [95% CI, 1.6-3.3]). The TB/DM association was significant at enrollment in both new and preexisting DM, but only persisted at follow-up in preexisting DM in patients with HIV-1 infection. CONCLUSIONS: Our study demonstrated high prevalence of transient hyperglycemia and a significant TB/DM and TB/IGR association at enrollment in newly diagnosed DM, but persistent hyperglycemia and TB/DM association in patients with HIV-1 infection and preexisting DM, despite TB therapy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kubjane M, Berkowitz N, Goliath R, et al. Tuberculosis, Human Immunodeficiency Virus, and the Association With Transient Hyperglycemia in Periurban South Africa. Clin Infect Dis. 2020. PMID: 31557282. doi:10.1093/cid/ciz928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。